142 related articles for article (PubMed ID: 37499454)
1. MYCT1 in cancer development: Gene structure, regulation, and biological implications for diagnosis and treatment.
Xu J; Sun Y; Fu W; Fu S
Biomed Pharmacother; 2023 Sep; 165():115208. PubMed ID: 37499454
[TBL] [Abstract][Full Text] [Related]
2. MYCT1-TV, a novel MYCT1 transcript, is regulated by c-Myc and may participate in laryngeal carcinogenesis.
Fu S; Guo Y; Chen H; Xu ZM; Qiu GB; Zhong M; Sun KL; Fu WN
PLoS One; 2011; 6(10):e25648. PubMed ID: 21998677
[TBL] [Abstract][Full Text] [Related]
3. Promoter hypermethylation-induced transcriptional down-regulation of the gene MYCT1 in laryngeal squamous cell carcinoma.
Yang M; Li W; Liu YY; Fu S; Qiu GB; Sun KL; Fu WN
BMC Cancer; 2012 Jun; 12():219. PubMed ID: 22672838
[TBL] [Abstract][Full Text] [Related]
4. Transmembrane domain is crucial to the subcellular localization and function of Myc target 1.
Wu S; Gui J; Yin X; Pan Q; Liu X; Chu L
J Cell Mol Med; 2016 Mar; 20(3):471-81. PubMed ID: 26710964
[TBL] [Abstract][Full Text] [Related]
5. YY1 directly suppresses MYCT1 leading to laryngeal tumorigenesis and progress.
Qu SY; Sun YY; Li YH; Xu ZM; Fu WN
Cancer Med; 2017 Jun; 6(6):1389-1398. PubMed ID: 28485541
[TBL] [Abstract][Full Text] [Related]
6. MYCT1 inhibits the EMT and migration of laryngeal cancer cells via the SP1/miR-629-3p/ESRP2 pathway.
Yue PJ; Sun YY; Li YH; Xu ZM; Fu WN
Cell Signal; 2020 Oct; 74():109709. PubMed ID: 32659265
[TBL] [Abstract][Full Text] [Related]
7. Nitrosative stress induces downregulation of ribosomal protein genes via MYCT1 in vascular smooth muscle cells.
Yan F; Wang J; Wu X; Lu XT; Wang Y; Cheng W; Cui XP; Jiang F; Guo XS
Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5653-5663. PubMed ID: 34604957
[TBL] [Abstract][Full Text] [Related]
8. miR-632 Functions as Oncogene in Hepatocellular Carcinoma via Targeting MYCT1.
Pu J; Wang J; Xu Z; Lu Y; Wu X; Wu Y; Shao Z; Tang Q; Wei H
Hum Gene Ther Clin Dev; 2019 Jun; 30(2):67-73. PubMed ID: 30982352
[TBL] [Abstract][Full Text] [Related]
9. Dual role of endothelial
Kabir AU; Subramanian M; Lee DH; Wang X; Krchma K; Wu J; Naismith T; Halabi CM; Kim JY; Pulous FE; Petrich BG; Kim S; Park HC; Hanson PI; Pan H; Wickline SA; Fremont DH; Park C; Choi K
Sci Transl Med; 2021 Mar; 13(583):. PubMed ID: 33658356
[TBL] [Abstract][Full Text] [Related]
10. MYCT1 represses apoptosis of laryngeal cancerous cells through the MAX/miR-181a/NPM1 pathway.
Wang HT; Tong X; Zhang ZX; Sun YY; Yan W; Xu ZM; Fu WN
FEBS J; 2019 Oct; 286(19):3892-3908. PubMed ID: 31152622
[TBL] [Abstract][Full Text] [Related]
11. miR-34a-5p suppresses the invasion and metastasis of liver cancer by targeting the transcription factor YY1 to mediate MYCT1 upregulation.
Xu XP; Peng XQ; Yin XM; Liu Y; Shi ZY
Acta Histochem; 2020 Sep; 122(6):151576. PubMed ID: 32778238
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of MYCT1 Inhibits Proliferation and Induces Apoptosis in Human Acute Myeloid Leukemia HL-60 and KG-1a Cells
Fu S; Fu Y; Chen F; Hu Y; Quan B; Zhang J
Front Pharmacol; 2018; 9():1045. PubMed ID: 30283340
[TBL] [Abstract][Full Text] [Related]
13. Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins.
Bucci B; D'Agnano I; Amendola D; Citti A; Raza GH; Miceli R; De Paula U; Marchese R; Albini S; Felsani A; Brunetti E; Vecchione A
Clin Cancer Res; 2005 Apr; 11(7):2756-67. PubMed ID: 15814658
[TBL] [Abstract][Full Text] [Related]
14. Small molecule selectively suppresses MYC transcription in cancer cells.
Bouvard C; Lim SM; Ludka J; Yazdani N; Woods AK; Chatterjee AK; Schultz PG; Zhu S
Proc Natl Acad Sci U S A; 2017 Mar; 114(13):3497-3502. PubMed ID: 28292893
[TBL] [Abstract][Full Text] [Related]
15. MYCT1 Inhibits the Adhesion and Migration of Laryngeal Cancer Cells Potentially Through Repressing Collagen VI.
Wang PP; Ding SY; Sun YY; Li YH; Fu WN
Front Oncol; 2020; 10():564733. PubMed ID: 33680912
[TBL] [Abstract][Full Text] [Related]
16. CREB promotes laryngeal cancer cell migration via MYCT1/NAT10 axis.
Zhang ZX; Zhang WN; Sun YY; Li YH; Xu ZM; Fu WN
Onco Targets Ther; 2018; 11():1323-1331. PubMed ID: 29563811
[TBL] [Abstract][Full Text] [Related]
17. MYCT-1 Gene Expression in Patients with Gastric Cancer: an Ex Vivo Study.
Dong X; Xue S; Chen C; Jiang Z; Wu X; Wang W
Appl Biochem Biotechnol; 2023 Dec; ():. PubMed ID: 38112991
[TBL] [Abstract][Full Text] [Related]
18. PGE2-driven expression of c-Myc and oncomiR-17-92 contributes to apoptosis resistance in NSCLC.
Krysan K; Kusko R; Grogan T; O'Hearn J; Reckamp KL; Walser TC; Garon EB; Lenburg ME; Sharma S; Spira AE; Elashoff D; Dubinett SM
Mol Cancer Res; 2014 May; 12(5):765-74. PubMed ID: 24469837
[TBL] [Abstract][Full Text] [Related]
19. TSA suppresses miR-106b-93-25 cluster expression through downregulation of MYC and inhibits proliferation and induces apoptosis in human EMC.
Zhao ZN; Bai JX; Zhou Q; Yan B; Qin WW; Jia LT; Meng YL; Jin BQ; Yao LB; Wang T; Yang AG
PLoS One; 2012; 7(9):e45133. PubMed ID: 23028803
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
Rivas MA; Venturutti L; Huang YW; Schillaci R; Huang TH; Elizalde PV
Breast Cancer Res; 2012 May; 14(3):R77. PubMed ID: 22583478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
